The official blog of the Lung Institute.

Lung Institute Expands To Nashville

20 Oct 2014
| Under COPD, Lung Disease, Treatments | Posted by | 0 Comments
Nashville Lung Institute

Company Looks to Help Patients with New Facility

Exciting news from the Lung Institute today! The company has opened its doors to a new clinic in Nashville, Tennessee! Patients will now be able to choose from two locations to help treat their pulmonary conditions.

The opening was marked by an official ribbon cutting ceremony from the medical staff, RMS corporate team, and members of the Nashville Chamber of Commerce. With Nashville being a hub for medical technology, this was a prime location to expand the Lung Institute brand. After the current success of treating 400 patients at the clinic in Tampa, FL., the new expansion will bring stem cell treatments and innovative medicine to the Nashville area.

Jack Coleman, Jr, MD, is the medical director for the Lung Institute in Nashville. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is Board Certified in Otolaryngology and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.

“I am very excited about these new facilities opening,” says Dr. Coleman. “The Lung Institute is providing innovative procedures for patients with debilitating conditions and will be a prime location for patients in Nashville.”

About the Lung Institute

Changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine, the Lung Institute has always committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. These doctors have established a patient treatment plan with the highest concern for patient safety and quality of care.

Stem Cell Therapy for Lung Disease

The Lung Institute utilizes autologous stem cells, derived from the patient’s own body for both the venous (blood-derived) stem cell procedures. During these procedures, stem cells are extracted, isolated and then immediately introduced back into the body where they then divide and replicate into healthy cells specialized to the damaged tissue. Since the treatment uses the body’s own stem cells, there is a less chance for rejection. Both bone marrow and venous stem cells have shown anti-inflammatory properties beneficial to patients with lung disease.

If you suffer from a lung disease or know a loved one that disease, then stem cell treatment is a viable option. If you have any questions, talk to one of our patient care coordinators today, contact us or call us at (800) 729-3065 to schedule a free consultation.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.